2seventy bio (TSVT) shares hit a 52-week low Thursday after partner Bristol Myers (BMY) reported a drop in sales for their multiple myeloma med.
https://seekingalpha.com/news/4025385-2seventy-stock-hits-new-52-week-low-on-abecma-sales-report
2seventy bio (TSVT) shares hit a 52-week low Thursday after partner Bristol Myers (BMY) reported a drop in sales for their multiple myeloma med.
https://seekingalpha.com/news/4025385-2seventy-stock-hits-new-52-week-low-on-abecma-sales-report
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.